Beleaguered liquor baron Vijay Mallya on Wednesday announced he will retire as chairman of Sanofi India and will not seek reelection as a director of the drug maker.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
Experts suggest six ways to play stocks that tank suddenly and make money as Sanjay Kumar Singh listens in
The bank wanted to run a background check on some Indian promoters.
A glance back at some of the important ups and down Indian Inc faced in 2018.
'A law firm checked credentials of Karan Ajit Judge and Nouam'
'Devyani -- she is a public servant and her personal life has already received far too much attention -- and her ambitious father now need to retreat to the background so that wiser diplomatic heads restore sanity to India-US relations as India prepares for parliamentary elections,' says Ambassador K C Singh.
The former McKinsey India head is presently on board of many big Indian conglomerates.
This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances